{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:38:11Z","timestamp":1789738691067,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":1100,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1593\/neo.101744","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:05:05Z","timestamp":1429794305000},"page":"461-IN12","source":"Crossref","is-referenced-by-count":62,"title":["Identification of an Exon 4-Deletion Variant of Epidermal Growth Factor Receptor with Increased Metastasis-Promoting Capacity"],"prefix":"10.1016","volume":"13","author":[{"given":"Hai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bizhi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianren","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.101744_bib1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1158\/0008-5472.CAN-05-1242","article-title":"Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis","volume":"66","author":"Xue","year":"2006","journal-title":"Cancer Res"},{"key":"10.1593\/neo.101744_bib2","first-page":"1299","article-title":"Activation of an EGFR\/neu chimeric receptor: early intracellular signals and cell proliferation responses","volume":"4","author":"Pandiella","year":"1989","journal-title":"Oncogene"},{"key":"10.1593\/neo.101744_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0360-3016(03)00511-X","article-title":"The epidermal growth factor receptor mediates radioresistance","volume":"57","author":"Liang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1593\/neo.101744_bib4","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1158\/0008-5472.CAN-04-2426","article-title":"Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor","volume":"65","author":"Ho","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.101744_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/CAD.0b013e3283330590","article-title":"Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities","volume":"20","author":"Modjtahedi","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1593\/neo.101744_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ccr.2008.03.015","article-title":"Survival of cancer cells is maintained by EGFR independent of its kinase activity","volume":"13","author":"Weihua","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1593\/neo.101744_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2009.01.019","article-title":"Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma","volume":"279","author":"Wang","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1593\/neo.101744_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0959-8049(92)90374-B","article-title":"EGF receptor amplification and expression in human brain tumours","volume":"28","author":"Chaffanet","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1593\/neo.101744_bib9","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1073\/pnas.91.16.7727","article-title":"A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity","volume":"91","author":"Nishikawa","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.101744_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/A:1005824802617","article-title":"The autocrine loop of TGF-\u03b1\/EGFR and brain tumors","volume":"35","author":"Tang","year":"1997","journal-title":"J Neurooncol"},{"key":"10.1593\/neo.101744_bib11","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1593\/neo.101744_bib12","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1038\/onc.2010.313","article-title":"EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism","volume":"29","author":"Pines","year":"2010","journal-title":"Oncogene"},{"key":"10.1593\/neo.101744_bib13","first-page":"463","article-title":"Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells","volume":"30","author":"Lankiewicz","year":"2008","journal-title":"Cell Oncol"},{"key":"10.1593\/neo.101744_bib14","first-page":"1383","article-title":"Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas","volume":"60","author":"Frederick","year":"2000","journal-title":"Cancer Res"},{"key":"10.1593\/neo.101744_bib15","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.febslet.2010.04.019","article-title":"Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy","volume":"584","author":"Pines","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1593\/neo.101744_bib16","first-page":"85","article-title":"Transformational and altered signal transduction by a naturally occurring mutant EGF receptor","volume":"13","author":"Moscatello","year":"1996","journal-title":"Oncogene"},{"key":"10.1593\/neo.101744_bib17","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1074\/jbc.273.5.2817","article-title":"Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor","volume":"273","author":"Antonyak","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.101744_bib18","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1039\/c001196g","article-title":"Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth","volume":"6","author":"Huang","year":"2010","journal-title":"Mol Biosyst"},{"key":"10.1593\/neo.101744_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1023\/A:1011177318162","article-title":"The type III epidermal growth factor receptor mutation: biological significance and potential target for anti-cancer therapy","volume":"12","author":"Pederson","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1593\/neo.101744_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1479-5876-3-38","article-title":"The natural history of EGFR and EGFRvIII in glioblastoma patients","volume":"3","author":"Heimberger","year":"2005","journal-title":"J Transl Med"},{"key":"10.1593\/neo.101744_bib21","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-06-0913","article-title":"Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting","volume":"12","author":"Sok","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.101744_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1073\/pnas.232686499","article-title":"A monoclonal antibody recognizing human cancers with amplification\/overexpression of the human epidermal growth factor receptor","volume":"100","author":"Jungbluth","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.101744_bib23","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1073\/pnas.0611693104","article-title":"A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors","volume":"104","author":"Scott","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.101744_bib24","series-title":"Therapeutic Monoclonal Antibodies: From Bench to Clinic","first-page":"675","article-title":"The formulation and delivery of monoclonal antibodies","author":"Sharma","year":"2009"},{"key":"10.1593\/neo.101744_bib25","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1200\/JCO.2010.28.6963","article-title":"Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma","volume":"28","author":"Sampson","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.101744_bib26","first-page":"232","article-title":"Clinical implications of the ErbB\/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer","volume":"1785","author":"Lafky","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1593\/neo.101744_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1078-0432.CCR-05-0934","article-title":"Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay","volume":"12","author":"Asano","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.101744_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0092-8674(02)00963-7","article-title":"Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains","volume":"110","author":"Ogiso","year":"2002","journal-title":"Cell"},{"key":"10.1593\/neo.101744_bib29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(02)00940-6","article-title":"Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor \u03b1","volume":"110","author":"Garrett","year":"2002","journal-title":"Cell"},{"key":"10.1593\/neo.101744_bib30","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1158\/0008-5472.CAN-05-0407","article-title":"Down-regulation of integrin \u03b12 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation","volume":"65","author":"Ning","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.101744_bib31","first-page":"432","article-title":"Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis","volume":"112","author":"Mrgineanu","year":"2008","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"10.1593\/neo.101744_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1083\/jcb.200308162","article-title":"Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of \u03b2-catenin signaling, Slug, and MAPK","volume":"163","author":"Conacci-Sorrell","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1593\/neo.101744_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ceb.2005.08.009","article-title":"The regulation of cadherin-mediated adhesion by tyrosine phosphorylation\/dephosphorylation of \u03b2-catenin","volume":"17","author":"Lilien","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"10.1593\/neo.101744_bib34","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1093\/nar\/24.20.4050","article-title":"A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor","volume":"24","author":"Reiter","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"10.1593\/neo.101744_bib35","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1074\/jbc.M005599200","article-title":"Glycosylation-induced conformational modification positively regulates receptor-receptor association","volume":"276","author":"Fernandez","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.101744_bib36","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1158\/1078-0432.CCR-08-1011","article-title":"Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer","volume":"15","author":"Pernas","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.101744_bib37","first-page":"120","article-title":"The complexity of targeting EGFR signalling in cancer: from expression to turnover","volume":"1766","author":"Sebastian","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1593\/neo.101744_bib38","first-page":"131","article-title":"A molecular crosstalk between E-cadherin and EGFR signaling networks","volume":"1","author":"Gavard","year":"2008"},{"key":"10.1593\/neo.101744_bib39","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1593\/neo.101744_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jim.2008.08.004","article-title":"Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines","volume":"339","author":"Schmittling","year":"2008","journal-title":"J Immunol Methods"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558611800643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558611800643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T07:29:04Z","timestamp":1537687744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558611800643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1476558611800643"],"URL":"https:\/\/doi.org\/10.1593\/neo.101744","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}